These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28987382)

  • 41. PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
    Yin S; Liu L; Brobbey C; Palanisamy V; Ball LE; Olsen SK; Ostrowski MC; Gan W
    Nat Commun; 2021 Jun; 12(1):3444. PubMed ID: 34103528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
    Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis.
    Chen D; Zeng S; Huang M; Xu H; Liang L; Yang X
    J Cell Mol Med; 2017 Apr; 21(4):781-790. PubMed ID: 27860244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
    Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
    Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial transcriptome in response to pharmacological methyltransferase inhibition.
    Okabe J; Fernandez AZ; Ziemann M; Keating ST; Balcerczyk A; El-Osta A
    ChemMedChem; 2014 Aug; 9(8):1755-62. PubMed ID: 24850797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A patent review of arginine methyltransferase inhibitors (2010-2018).
    Li X; Wang C; Jiang H; Luo C
    Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
    Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
    Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
    Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
    J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.
    Chiang K; Zielinska AE; Shaaban AM; Sanchez-Bailon MP; Jarrold J; Clarke TL; Zhang J; Francis A; Jones LJ; Smith S; Barbash O; Guccione E; Farnie G; Smalley MJ; Davies CC
    Cell Rep; 2017 Dec; 21(12):3498-3513. PubMed ID: 29262329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell metabolic profiling of colorectal cancer via
    Ge S; Zhang Q; Tian Y; Hao L; Duan J; Zhang B
    Clin Chim Acta; 2020 Nov; 510():291-297. PubMed ID: 32707041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of protein arginine methyltransferase 5 in human cancers.
    Xiao W; Chen X; Liu L; Shu Y; Zhang M; Zhong Y
    Biomed Pharmacother; 2019 Jun; 114():108790. PubMed ID: 30903920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
    Wang M; Fuhrmann J; Thompson PR
    Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
    Li X; Wang X; Zhao J; Wang J; Wu J
    J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
    Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
    Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis.
    Wang K; Chen Y; Zhang M; Wang S; Yao S; Gong Z; Fei B; Huang Z
    Biochem Pharmacol; 2024 Aug; 226():116367. PubMed ID: 38876258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity-based protein profiling of protein arginine methyltransferase 1.
    Obianyo O; Causey CP; Jones JE; Thompson PR
    ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer.
    Kanda M; Shimizu D; Fujii T; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2016 Sep; 49(3):1195-202. PubMed ID: 27315569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
    Li M; An W; Xu L; Lin Y; Su L; Liu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome.
    Girardot M; Hirasawa R; Kacem S; Fritsch L; Pontis J; Kota SK; Filipponi D; Fabbrizio E; Sardet C; Lohmann F; Kadam S; Ait-Si-Ali S; Feil R
    Nucleic Acids Res; 2014 Jan; 42(1):235-48. PubMed ID: 24097435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.